Vivani Medical (NASDAQ:VANI) versus FONAR (NASDAQ:FONR) Head-To-Head Comparison

Vivani Medical (NASDAQ:VANI) and FONAR (NASDAQ:FONR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Profitability

This table compares Vivani Medical and FONAR’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-44.95%	-35.23%
FONAR	10.63%	8.39%	6.25%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Vivani Medical and FONAR, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	0	0	1	0	3.00
FONAR	0	0	0	0	N/A

Vivani Medical presently has a consensus target price of $7.00, indicating a potential upside of 678.04%. Given Vivani Medical’s higher probable upside, analysts plainly believe Vivani Medical is more favorable than FONAR.

Insider and Institutional Ownership

8.4% of Vivani Medical shares are held by institutional investors. Comparatively, 46.1% of FONAR shares are held by institutional investors. 55.6% of Vivani Medical shares are held by company insiders. Comparatively, 1.6% of FONAR shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Vivani Medical and FONAR’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$13.89 million	($0.39)	-2.31
FONAR	$97.59 million	1.10	$12.44 million	N/A	N/A

FONAR has higher revenue and earnings than Vivani Medical.

Volatility and Risk

Vivani Medical has a beta of 2.6, indicating that its share price is 160% more volatile than the S&P 500. Comparatively, FONAR has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500.

Summary

FONAR beats Vivani Medical on 6 of the 10 factors compared between the two stocks.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

About FONAR

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.